Biogened S.A. (WSE:BGD)
Poland
· Delayed Price · Currency is PLN 19.10
-0.70 (-3.54%)
At close: Feb 26, 2026
Biogened Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 114.04 | 110.93 | 95.56 | 79.62 | 65.32 | Upgrade
|
| Revenue Growth (YoY) | 2.80% | 16.09% | 20.02% | 21.89% | 35.15% | Upgrade
|
| Cost of Revenue | 41 | 34.28 | 32.07 | 22.18 | 23 | Upgrade
|
| Gross Profit | 73.04 | 76.65 | 63.49 | 57.44 | 42.32 | Upgrade
|
| Selling, General & Admin | 63.7 | 66.88 | 54.62 | 41.86 | 35.29 | Upgrade
|
| Other Operating Expenses | 0.23 | 0.72 | 0.7 | 7.2 | 2.43 | Upgrade
|
| Operating Expenses | 63.93 | 67.6 | 55.32 | 49.06 | 37.73 | Upgrade
|
| Operating Income | 9.11 | 9.06 | 8.16 | 8.38 | 4.59 | Upgrade
|
| Interest Expense | -2.21 | -2.37 | -2.16 | -1.7 | -0.6 | Upgrade
|
| Interest & Investment Income | - | 0 | 0 | 0 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.43 | -0.17 | 0 | -0.32 | -0.16 | Upgrade
|
| EBT Excluding Unusual Items | 6.48 | 6.52 | 6.01 | 6.36 | 3.84 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 0.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.42 | 0.32 | 0.88 | 0.03 | -0 | Upgrade
|
| Other Unusual Items | - | 0.85 | - | - | - | Upgrade
|
| Pretax Income | 6.9 | 7.69 | 6.89 | 6.39 | 4.33 | Upgrade
|
| Income Tax Expense | 2.28 | 1.87 | 1.79 | 3.01 | 2.37 | Upgrade
|
| Net Income | 4.62 | 5.82 | 5.1 | 3.38 | 1.96 | Upgrade
|
| Net Income to Common | 4.62 | 5.82 | 5.1 | 3.38 | 1.96 | Upgrade
|
| Net Income Growth | -20.59% | 14.22% | 50.74% | 72.46% | 57.92% | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| EPS (Basic) | 1.88 | 2.37 | 2.08 | 1.38 | 0.80 | Upgrade
|
| EPS (Diluted) | 1.88 | 2.37 | 2.08 | 1.38 | 0.80 | Upgrade
|
| EPS Growth | -20.59% | 14.22% | 50.74% | 72.46% | 57.92% | Upgrade
|
| Free Cash Flow | 5.13 | -1.49 | 7.72 | -3.35 | 1.57 | Upgrade
|
| Free Cash Flow Per Share | 2.09 | -0.61 | 3.14 | -1.36 | 0.64 | Upgrade
|
| Dividend Per Share | - | 0.500 | 0.500 | 0.400 | - | Upgrade
|
| Dividend Growth | - | - | 25.00% | - | - | Upgrade
|
| Gross Margin | 64.05% | 69.10% | 66.44% | 72.14% | 64.78% | Upgrade
|
| Operating Margin | 7.99% | 8.16% | 8.54% | 10.52% | 7.03% | Upgrade
|
| Profit Margin | 4.05% | 5.25% | 5.33% | 4.25% | 3.00% | Upgrade
|
| Free Cash Flow Margin | 4.50% | -1.35% | 8.08% | -4.21% | 2.41% | Upgrade
|
| EBITDA | 13.49 | 13.19 | 11.69 | 11.31 | 7.47 | Upgrade
|
| EBITDA Margin | 11.82% | 11.89% | 12.23% | 14.21% | 11.44% | Upgrade
|
| D&A For EBITDA | 4.37 | 4.13 | 3.52 | 2.94 | 2.88 | Upgrade
|
| EBIT | 9.11 | 9.06 | 8.16 | 8.38 | 4.59 | Upgrade
|
| EBIT Margin | 7.99% | 8.16% | 8.54% | 10.52% | 7.03% | Upgrade
|
| Effective Tax Rate | 33.00% | 24.33% | 26.01% | 47.09% | 54.71% | Upgrade
|
| Revenue as Reported | 114.04 | 110.93 | 95.56 | 79.62 | 65.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.